在老年AHF患者中开发AMI的预测名录:一个回顾性分析
Qili Yu1, Tingting Song1, Rui Cui1
1Department of Cardiology, The First Hospital of Qinhuangdao, Qinhuangdao, Hebei, China.
Frontiers in medicine
|July 24, 2025
概括
这项研究开发了一种预测模型,用于识别急性心肌梗塞 (AMI) 高风险的老年患者在急性心力衰竭 (AHF) 住院期间. 该模型有助于早期检测和临床决策,以获得更好的患者结果.
科学领域:
- 心脏病学 心脏病学
- 老年病的医生 老年病的医生
- 医疗信息学 医疗信息学
背景情况:
- 患有急性心力衰竭 (AHF) 的老年患者经历急性心肌梗塞 (AMI) 面临严重的疾病和不良预后.
- 早期识别风险因素对于及时干预这一脆弱人群至关重要.
研究的目的:
- 分析与AHF住院的老年患者的AMI相关的风险因素.
- 开发和验证早期AMI风险评估的临床预测模型.
主要方法:
- 在2019年10月至2023年12月期间住院的1,904名老年AHF患者的回顾性分析.
- 利用LASSO和后勤回归来确定AMI的独立风险因素.
- 构建了一个名录模型,并使用AUC,ROC,决策曲线分析和临床影响曲线验证了其预测性能.
主要成果:
- 确定了年龄,冠心病,糖尿病,肺部感染,心室节律失常,高脂血症,低albuminemia,左心室静脉直径 (LVDD) 和左心室射出分数 (LVEF) 作为AMI的独立风险因素.
- 开发的预测模型表现出强的性能,AUC为0.780,准确率为91.3%,特异性为91.4%.
结论:
- 成功开发了一种强大的多变量预测模型,用于老年住院AHF患者的AMI风险.
- 该模型是临床医生提供一个有价值的工具,以促进早期风险识别和干预,改善患者管理.
更多相关视频
04:05Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
2.2K
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
3.5K
相关概念视频
Heart Failure IV: Classification and Diagnostic Evaluation
33
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
33
Heart Failure VI: Adjunct Therapies
28
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
28
